Henry Butt
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Henry L. Butt, MSc, PhD, is the Director of Bioscreen (a laboratory specializing in fecal microbial analysis) and a researcher in Newcastle, Australia.
Books[edit | edit source]
- 2014, Chapter Five in Advances in Clinical Chemistry, Vol. 66, published by Elsevier; "Metabolism in Chronic Fatigue Syndrome," by Christopher W. Armstrong, Neil R. McGregor, Henry L. Butt, and Paul R. Gooley[1]
Notable studies[edit | edit source]
- 1996, Preliminary determination of the association between symptom expression and urinary metabolites in subjects with chronic fatigue syndrome
- 1996, Preliminary determination of a molecular basis of chronic fatigue syndrome
- 1997, A Preliminary Assessment of the Association of SCL-90-R Psychological Inventory Responses with Changes in Urinary Metabolites in Patients with Chronic Fatigue Syndrome[2]
- 1998, Immunological and Haematological Parameters in Patients with Chronic Fatigue Syndrome[3] - (Abstract)
- 2000, Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome[4]
- 2000, Erythrocyte Morphology in Rheumatoid Arthritis and Chronic Fatigue Syndrome: A Preliminary Study[5]
- 2000, Investigation of Erythrocyte Oxidative Damage in Rheumatoid Arthritis and Chronic Fatigue Syndrome[6]
- 2007, Hematologic and urinary excretion anomalies in patients with chronic fatigue syndrome[7] - (Abstract)
- 2009, Increased D-Lactic Acid Intestinal Bacteria in Patients with Chronic Fatigue Syndrome[8]
- 2014, Metabolism in chronic fatigue syndrome[9] - (Abstract)
- 2015, Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot study (Jackson ML, Henry Butt, Ball M, Lewis DP, Bruck D)
- 2015, Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients[10]
- 2016, Widespread pain and altered renal function in ME/CFS patients[11]
- 2016, Support for the Microgenderome: Associations in a Human Clinical Population[12] - (Full Text)
- 2017, Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and d-lactic acidosis: a systematic review[13] - (Full Text)
- 2017, The association of fecal microbiota and fecal, blood serum and urine metabolites in myalgic encephalomyelitis/chronic fatigue syndrome[14]
- 2018, Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons[15] - (Full Text) (Correction)
- 2012, NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome[16] - (Abstract)
Talks and interviews[edit | edit source]
Online presence[edit | edit source]
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ Armstrong, Christopher W.; McGregor, Neil R.; Butt, Henry L.; Gooley, Paul R. (2014). "Metabolism in Chronic Fatigue Syndrome". Advances in Clinical Chemistry: 121–172.
- ↑ N.R. McGregor, R.H. Dunstan, H.L. Butt, T.K. Roberts, I.J. Klineberg, and M. Zerbes. (1997). A Preliminary Assessment of the Association of SCL-90-R Psychological Inventory Responses with Changes in Urinary Metabolites in Patients with Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome, Vol. 3, Iss. 1, pp 17-37. http://dx.doi.org/10.1300/J092v03n01_03
- ↑ Roberts, Timothy K.; McGregor, Neil R.; Dunstan, R. Hugh; Donohoe, Mark; Murdoch, Raymond N.; Zhang, S.; Hope, D.; Butt, Henry L.; Watkins, Jennifer A.; Taylor, Warren G. (1998). "Immunological and Haematological Parameters in Patients with Chronic Fatigue Syndrome". Journal of Chronic Fatigue Syndrome. 4 (4): 51–65. doi:10.1300/J092v04n04_05.
- ↑ Richards, RS; Roberts, TK; McGregor, NR; Dunstan, RH; Butt, HL (2000), "Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome", Redox Report, 5 (1): 35-41, doi:10.1179/rer.2000.5.1.35, PMID 10905542
- ↑ R. S. Richards, T. K. Roberts,D. Mathers, R. H. Dunstan, N. R. McGregor & H. L. Butt. (2000). Erythrocyte Morphology in Rheumatoid Arthritis and Chronic Fatigue Syndrome: A Preliminary Study. Journal of Chronic Fatigue Syndrome, Vol. 6, Iss. 1, pp. 23-35. http://dx.doi.org/10.1300/J092v06n01_03
- ↑ R. S. Richards, T. K. Roberts,D. Mathers, R. H. Dunstan, N. R. McGregor & H. L. Butt. (2000). Investigation of Erythrocyte Oxidative Damage in Rheumatoid Arthritis and Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome, Vol. 6, Iss. 1, pp. 37-46. http://dx.doi.org/10.1300/J092v06n01_04
- ↑ Niblett, Suzanne H.; King, Katrina E.; Dunstan, R. Hugh; Clifton-Bligh, Phillip; Hoskin, Leigh A.; Roberts, Timothy K.; Fulcher, Greg R.; McGregor, Neil R.; Dunsmore, Julie C.; Butt, Henry; Klineberg, Iven; Rothkirch, T.B. (September 2007). "Hematologic and Urinary Excretion Anomalies in Patients with Chronic Fatigue Syndrome". Experimental Biology and Medicine. 232 (8): 1041–1049. doi:10.3181/0702-rm-44. ISSN 1535-3702.
- ↑ Sheedy, John R.; Wettenhall, Richard E.H.; Scanlon, Denis; Gooley, Paul R.; Lewis, Donald P.; McGregor, Neil; Stapleton, David I.; Butt, Henry L.; De Meirleir, Kenny L. (July 2009). "Increased d-lactic Acid intestinal bacteria in patients with chronic fatigue syndrome". In Vivo (Athens, Greece). 23 (4): 621–628. ISSN 0258-851X. PMID 19567398.
- ↑ Armstrong, Christopher W.; McGregor, Neil R.; Butt, Henry L.; Gooley, Paul R. (2014). "Metabolism in chronic fatigue syndrome". Advances in Clinical Chemistry. 66: 121–172. ISSN 0065-2423. PMID 25344988.
- ↑ Armstrong, Christopher W.; McGregor, Neil R.; Lewis, Donald P.; Butt, Henry L.; Gooley, Paul R. (2015), "Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients", Metabolomics, 11 (6): 1626–1639, doi:10.1007/s11306-015-0816-5
- ↑ McGregor, Neil R.; Armstrong, Christopher W.; Lewis, Donald P.; Butt, Henry L.; Gooley, Paul R. (July 2016). "Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients". Fatigue: Biomedicine, Health & Behavior. 4 (3): 132–145. doi:10.1080/21641846.2016.1207400.
- ↑ Wallis, Amy; Butt, Henry L; Ball, Michelle; Lewis, Donald P; Bruck, Dorothy (January 13, 2016), "Support for the Microgenderome: Associations in a Human Clinical Population", Scientific Reports, 6: 19171, doi:10.1038/srep19171, PMID 26757840
- ↑ Wallis, Amy; Ball, Michelle; McKechnie, Sandra; Butt, Henry L; Lewis, Donald P; Bruck, Dorothy (2017), "Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and d-lactic acidosis: a systematic review", Journal of Translational Medicine (15): 129, doi:10.1186/s12967-017-1229-1
- ↑ Armstrong, Christopher W.; McGregor, Neil R.; Lewis, Donald P.; Butt, Henry L.; Gooley, Paul R. (2017), "The association of fecal microbiota and fecal, blood serum and urine metabolites in myalgic encephalomyelitis/chronic fatigue syndrome", Metabolomics, 13 (1), doi:10.1007/s11306-016-1145-z
- ↑ Wallis, Amy; Ball, Michelle; Butt, Henry L; Lewis, Donald P; McKechnie, Sandra; Paull, Phillip; Jaa-Kwee, Amber; Bruck, Dorothy (2018), "Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons", Journal of Translational Medicine, 16 (1): 24, doi:10.1186/s12967-018-1392-z
- ↑ Armstrong, Christopher W.; McGregor, Neil R.; Sheedy, John R.; Buttfield, Ian; Butt, Henry L.; Gooley, Paul R. (2012), "NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome", Clinica Chimica Acta, 413 (19–20): 1525–1531, doi:10.1016/j.cca.2012.06.022
